VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
COGT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
COGTCogent Biosciences, Inc.
$38.74$6.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCOGTQuarterly Financials

Cogent Biosciences, Inc. (COGT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Cogent Biosciences, Inc. (COGT) quarterly income statement — complete revenue, gross profit & net income history

COGT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %-------------------100%-100%
Cost of Goods Sold1.16M1.18M01.16M0000000000000000
COGS % of Revenue--------------------
Gross Profit-1.16M-1.18M0-1.16M0000000000000000
Gross Margin %--------------------
Gross Profit Growth %------------------100%100%
Operating Expenses102.45M98.32M83.36M74.42M74.93M73.73M75.41M64.39M62.4M58.23M59.58M47.09M43.24M43.74M36.82M35.85M31.42M25.64M19.82M17.29M
OpEx % of Revenue--------------------
Selling, General & Admin28.24M23.93M14.37M13.38M11.9M11.69M11.8M10.09M9.7M9.51M9.45M8.21M7.2M7M6.88M6.38M5.95M5.13M5.02M4.9M
SG&A % of Revenue--------------------
Research & Development75.36M74.38M68.99M61.05M63.03M62.05M63.61M54.29M52.7M48.72M50.13M38.87M36.04M36.74M29.94M29.48M25.47M20.51M14.8M12.39M
R&D % of Revenue--------------------
Other Operating Expenses-1000K0000000000000000000
Operating Income-103.61M-99.49M-83.36M-75.58M-74.93M-73.73M-75.41M-64.39M-62.4M-58.23M-59.58M-47.09M-43.24M-43.74M-36.82M-35.85M-31.42M-25.64M-19.82M-17.29M
Operating Margin %--------------------
Operating Income Growth %-38.27%-34.94%-10.53%-17.39%-20.08%-26.63%-26.58%-36.75%-44.33%-33.11%-61.81%-31.32%-37.62%-70.61%-85.79%-107.35%-145.45%-123.81%65.35%-133.58%
EBITDA-102.45M-102.43M-82.71M-74.42M-73.8M-72.63M-74.32M-63.31M-61.34M-57.43M-58.73M-45.87M-42.51M-42.81M-33.11M-35.19M-30.86M-25.57M-19.3M-16.38M
EBITDA Margin %--------------------
EBITDA Growth %-38.83%-41.04%-11.3%-17.56%-20.31%-26.45%-26.55%-38.02%-44.28%-34.17%-77.36%-30.37%-37.77%-67.4%-71.51%-114.83%-141.4%-123.55%66.18%-130.13%
D&A (Non-Cash Add-back)1.16M-2.94M641K1.16M1.14M1.11M1.1M1.08M1.07M794K855K1.22M723K937K3.71M670K560K68K514K914K
EBIT-103.61M-105.74M-79.47M-73.22M-74.93M-73.73M-75.41M-58.95M-62.4M-58.23M-59.58M-47.09M-43.24M-43.74M-36.82M-35.85M-31.42M-25.64M-19.82M-17.29M
Net Interest Income6.39M4.19M2.43M2.06M2.95M3.86M4.78M5.39M4.06M3.87M4.2M2.74M2.27M2.11M1.5M272K107K107K115K120K
Interest Income7.61M5.48M3.89M2.37M2.95M3.86M4.78M5.39M4.06M3.87M4.2M2.74M2.27M2.11M1.5M272K107K107K115K120K
Interest Expense1.21M1.29M1.46M314K0000000000000000
Other Income/Expense6.25M-3M2.42M2.05M2.95M5.81M4.78M5.44M4.06M3.86M4.2M3.01M4.65M4.13M1.76M928K784K728K735K743K
Pretax Income-97.35M-102.49M-80.93M-73.53M-71.99M-67.93M-70.63M-58.95M-58.35M-54.37M-55.38M-44.08M-38.59M-39.62M-35.06M-34.93M-30.63M-24.91M-19.08M-16.55M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-97.35M-102.49M-80.93M-73.53M-71.99M-67.93M-70.63M-58.95M-58.35M-54.37M-55.38M-44.08M-38.59M-39.62M-35.06M-34.93M-30.63M-24.91M-19.08M-16.55M
Net Margin %--------------------
Net Income Growth %-35.24%-50.89%-14.58%-24.73%-23.37%-24.95%-27.54%-33.75%-51.21%-37.22%-57.95%-26.19%-25.96%-59.03%-83.72%-111.05%-161.2%-119.72%61.82%-123.85%
Net Income (Continuing)-97.35M-102.49M-80.93M-73.53M-71.99M-67.93M-70.63M-58.95M-58.35M-54.37M-55.38M-44.08M-38.59M-39.62M-35.06M-34.93M-30.63M-24.91M-19.08M-16.55M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.60-1.13-0.71-0.64-0.52-0.61-0.64-0.59-0.62-0.63-0.64-0.59-0.48-0.50-0.48-0.71-0.66-0.57-0.48-0.43
EPS Growth %-15.38%-85.25%-10.94%-8.47%16.13%3.17%0%0%-29.17%-26%-33.33%16.9%27.27%12.28%0%-65.12%-94.12%47.22%90.53%54.74%
EPS (Basic)-0.60-1.13-0.71-0.64-0.52-0.61-0.64-0.59-0.62-0.63-0.64-0.59-0.48-0.50-0.48-0.71-0.66-0.57-0.48-0.43
Diluted Shares Outstanding67.41M67.6M114.47M114.47M113.31M110.46M110.17M99.24M94.8M86.73M86.17M74.75M70.73M70.49M69.58M49.39M45.11M43.81M39.85M38.44M
Basic Shares Outstanding67.41M67.6M114.47M114.47M113.31M110.46M110.17M99.24M94.8M86.73M86.17M74.75M70.73M70.49M69.58M49.39M45.11M43.81M39.85M38.44M
Dividend Payout Ratio--------------------